About Timothy Gleeson
Timothy Gleeson is chief executive officer and president of BRIJ Medical. The company makes devices that cover, protect and reinforce surgical incisions. Its Brijjit device offloads tension on an incision. Its BRIJ-SEAL device adds a 14-day bacterial barrier. Gleeson is also a director of the company.
Gleeson is the executive quoted in the company's releases. In December 2024 he commented on a national group purchasing agreement with Premier. In July 2025 he commented on a federal catalog listing that gives VA and DoD providers access to Brijjit. On November 3, 2026, the company closed a $5 million round led by its board. It had first aimed to raise $3 million.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Timothy Gleeson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timothy Gleeson works with at each company, as listed on that company's latest Form D.
